DIRAS3 regulates the autophagosome initiation complex in dormant ovarian cancer cells

Autophagy

Volumn 10, Issue 6, 2014, Pages 1071-1092

  Lu, Zhen ^a   Baquero, Maria T ^a   Yang, Hailing ^a   Yang, Maojie ^a   Reger, Albert S ^b   Kim, Choel ^b   Levine, Douglas A ^c   Clarke, Charlotte H ^a   Liao, Warren S L ^a   Bast Jr , Robert C ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Autophagy; BECN1; DIRAS3; Ovarian cancer; Second look surgery

Indexed keywords

ATG14 PROTEIN; BECLIN 1; CA 125 ANTIGEN; DIRAS3 PROTEIN; PIK3C3 PROTEIN; PIK3R4 PROTEIN; PROTEIN BCL 2; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; AMINO ACID; APOPTOSIS REGULATORY PROTEIN; ATG12 PROTEIN, HUMAN; ATG14 PROTEIN, HUMAN; BECN1 PROTEIN, HUMAN; DIRAS3 PROTEIN, HUMAN; LIGHT CHAIN 3, HUMAN; MEMBRANE PROTEIN; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; MUTANT PROTEIN; RECOMBINANT PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RNA; SUMO PROTEIN; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ARTICLE; AUTOPHAGOSOME; AUTOPHAGOSOME INITIATION COMPLEX; AUTOPHAGY; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; DELETION MUTANT; DIMERIZATION; DORMANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KWASHIORKOR; MAJOR CLINICAL STUDY; MEMBRANE VESICLE; OVARIAN CANCER CELL LINE; OVARY CANCER; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TUMOR SUPPRESSOR GENE; CHEMISTRY; FEMALE; GENETICS; METABOLISM; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; PHAGOSOME; PHYSIOLOGY; PROTEIN DOMAIN; PROTEIN MULTIMERIZATION; TUMOR CELL LINE;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; AMINO ACIDS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELL LINE, TUMOR; FEMALE; HUMANS; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MUTANT PROTEINS; OVARIAN NEOPLASMS; PHAGOSOMES; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; RECOMBINANT PROTEINS; RHO GTP-BINDING PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS;

EID: 84903603624     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.28577     Document Type: Article

References (56)

1. Levine B, Klionsky DJ. Development by selfdigestion: molecular mechanisms and biological functions of autophagy. Dev Cell 2004; 6:463-77; PMID:15068787; http://dx.doi.org/10.1016/S1534-5807(04)00099-1 (Pubitemid 38456176)
2. Klionsky DJ. The molecular machinery of autophagy: unanswered questions. J Cell Sci 2005; 118:7-18; PMID:15615779; http://dx.doi.org/10.1242/jcs.01620 (Pubitemid 40277100)
3. Bray K, Mathew R, Lau A, Kamphorst JJ, Fan J, Chen J, Chen HY, Ghavami A, Stein M, DiPaola RS, et al. Autophagy suppresses RIP kinase-dependent necrosis enabling survival to mTOR inhibition. PLoS One 2012; 7:e41831; PMID:22848625; http://dx.doi.org/10.1371/journal.pone.0041831
4. Yorimitsu T, Klionsky DJ. Autophagy: molecular machinery for self-eating. Cell Death Differ 2005; 12(Suppl 2):1542-52; PMID:16247502; http://dx.doi.org/10.1038/sj.cdd.4401765 (Pubitemid 41553991)
5. Matsunaga K, Saitoh T, Tabata K, Omori H, Satoh T, Kurotori N, Maejima I, Shirahama-Noda K, Ichimura T, Isobe T, et al. Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nat Cell Biol 2009; 11:385-96; PMID:19270696; http://dx.doi.org/10.1038/ncb1846
6. Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, Iemura S, Natsume T, Takehana K, Yamada N, et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell 2009; 20:1981-91; PMID:19211835; http://dx.doi.org/10.1091/mbc.E08-12-1248
7. He C, Levine B. The Beclin 1 interactome. Curr Opin Cell Biol 2010; 22:140-9; PMID:20097051; http://dx.doi.org/10.1016/j.ceb.2010.01.001
8. Sun Q, Fan W, Chen K, Ding X, Chen S, Zhong Q. Identification of Barkor as a mammalian autophagy-specific factor for Beclin 1 and class III phosphatidylinositol 3-kinase. Proc Natl Acad Sci U S A 2008; 105:19211-6; PMID:19050071; http://dx.doi.org/10.1073/pnas.0810452105
9. Itakura E, Kishi C, Inoue K, Mizushima N. Beclin forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol Biol Cell 2008; 19:5360-72; PMID:18843052; http://dx.doi.org/10.1091/mbc.E08-01-0080
10. Wu X, Liang L, Dong L, Yu Z, Fu X. Effect of ARHI on lung cancer cell proliferation, apoptosis and invasion in vitro. Mol Biol Rep 2013; 40:2671-8; PMID:23247805; http://dx.doi.org/10.1007/s11033-012-2353-x
11. Yu Y, Xu F, Peng H, Fang X, Zhao S, Li Y, Cuevas B, Kuo WL, Gray JW, Siciliano M, et al. NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc Natl Acad Sci U S A 1999; 96:214-9; PMID:9874798; http://dx.doi.org/10.1073/pnas.96.1.214 (Pubitemid 29036079)
12. Dalai I, Missiaglia E, Barbi S, Butturini G, Doglioni C, Falconi M, Scarpa A. Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors. Neoplasia 2007; 9:181-3; PMID:17401457; http://dx.doi.org/10.1593/neo.06838 (Pubitemid 46457234)
13. Rosen DG, Wang L, Jain AN, Lu KH, Luo RZ, Yu Y, Liu J, Bast RC Jr. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival. Clin Cancer Res 2004; 10:6559-66; PMID:15475444; http://dx.doi.org/10.1158/1078-0432.CCR-04-0698 (Pubitemid 39346551)
14. Wang L, Hoque A, Luo RZ, Yuan J, Lu Z, Nishimoto A, Liu J, Sahin AA, Lippman SM, Bast RC Jr., et al. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer. Clin Cancer Res 2003; 9:3660-6; PMID:14506155 (Pubitemid 37169232)
15. Feng W, Marquez RT, Lu Z, Liu J, Lu KH, Issa JP, Fishman DM, Yu Y, Bast RC Jr. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Cancer 2008; 112:1489-502; PMID:18286529; http://dx.doi.org/10. 1002/cncr.23323 (Pubitemid 351441161)
16. Feng W, Shen L, Wen S, Rosen DG, Jelinek J, Hu X, Huan S, Huang M, Liu J, Sahin AA, et al. Correlation between CpG methylation profiles and hormone receptor status in breast cancers. Breast Cancer Res 2007; 9:R57; PMID:17764565; http://dx.doi.org/10.1186/bcr1762
17. Fujii S, Luo RZ, Yuan J, Kadota M, Oshimura M, Dent SR, Kondo Y, Issa JP, Bast RC Jr., Yu Y. Reactivation of the silenced and imprinted alleles of ARHI is associated with increased histone H3 acetylation and decreased histone H3 lysine 9 methylation. Hum Mol Genet 2003; 12:1791-800; PMID:12874100; http://dx.doi.org/10.1093/hmg/ddg204 (Pubitemid 36944134)
18. Hisatomi H, Nagao K, Wakita K, Kohno N. ARHI/NOEY2 inactivation may be important in breast tumor pathogenesis. Oncology 2002; 62:136-40; PMID:11914599; http://dx.doi.org/10.1159/000048259 (Pubitemid 34253083)
19. Yu Y, Fujii S, Yuan J, Luo RZ, Wang L, Bao J, Kadota M, Oshimura M, Dent SR, Issa JP, et al. Epigenetic regulation of ARHI in breast and ovarian cancer cells. Ann N Y Acad Sci 2003; 983:268-77; PMID:12724231; http://dx.doi.org/10. 1111/j.1749-6632.2003.tb05981.x (Pubitemid 36399339)
20. Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, et al. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Cancer Res 2003; 63:4174-80; PMID:12874023 (Pubitemid 36917943)
21. Lu Z, Luo RZ, Peng H, Rosen DG, Atkinson EN, Warneke C, Huang M, Nishmoto A, Liu J, Liao WS, et al. Transcriptional and posttranscriptional downregulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer. Clin Cancer Res 2006; 12:2404-13; PMID:16638845; http://dx.doi.org/10. 1158/1078-0432.CCR-05-1036
22. Lu Z, Luo RZ, Lu Y, Zhang X, Yu Q, Khare S, Kondo S, Kondo Y, Yu Y, Mills GB, et al. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J Clin Invest 2008; 118:3917-29; PMID:19033662
23. Kueck A, Opipari AW Jr., Griffith KA, Tan L, Choi M, Huang J, Wahl H, Liu JR. Resveratrol inhibits glucose metabolism in human ovarian cancer cells. Gynecol Oncol 2007; 107:450-7; PMID:17825886; http://dx.doi.org/10.1016/j.ygyno. 2007.07.065 (Pubitemid 350160855)
24. Bjørkøy G, Lamark T, Pankiv S, Øvervatn A, Brech A, Johansen T. Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol 2009; 452:181-97; PMID:19200883; http://dx.doi.org/10.1016/S0076-6879(08)03612-4
25. Walczak M, Martens S. Dissecting the role of the Atg12-Atg5-Atg16 complex during autophagosome formation. Autophagy 2013; 9:424-5; PMID:23321721; http://dx.doi.org/10.4161/auto.22931
26. Matsushita M, Suzuki NN, Obara K, Fujioka Y, Ohsumi Y, Inagaki F. Structure of Atg5. Atg16, a complex essential for autophagy. J Biol Chem 2007; 282:6763-72; PMID:17192262; http://dx.doi.org/10.1074/jbc.M609876200 (Pubitemid 47100840)
27. Jung CH, Jun CB, Ro SH, Kim YM, Otto NM, Cao J, Kundu M, Kim DH. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell 2009; 20:1992-2003; PMID:19225151; http://dx.doi.org/10.1091/mbc. E08-12-1249
28. Ganley IG, Lam H, Wang J, Ding X, Chen S, Jiang X. ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. J Biol Chem 2009; 284:12297-305; PMID:19258318; http://dx.doi.org/10.1074/jbc.M900573200
29. Bodemann BO, Orvedahl A, Cheng T, Ram RR, Ou YH, Formstecher E, Maiti M, Hazelett CC, Wauson EM, Balakireva M, et al. RalB and the exocyst mediate the cellular starvation response by direct activation of autophagosome assembly. Cell 2011; 144:253-67; PMID:21241894; http://dx.doi.org/10.1016/j.cell.2010.12. 018
30. Tanida I. Autophagy basics. Microbiol Immunol 2011; 55:1-11; PMID:21175768; http://dx.doi.org/10.1111/j.1348-0421.2010.00271.x
31. Tanida I. Autophagosome formation and molecular mechanism of autophagy. Antioxid Redox Signal 2011; 14:2201-14; PMID:20712405; http://dx.doi.org/10. 1089/ars.2010.3482
32. Suzuki K, Kirisako T, Kamada Y, Mizushima N, Noda T, Ohsumi Y. The pre-autophagosomal structure organized by concerted functions of APG genes is essential for autophagosome formation. EMBO J 2001; 20:5971-81; PMID:11689437; http://dx.doi.org/10.1093/emboj/20.21.5971 (Pubitemid 33049272)
33. Fimia GM, Stoykova A, Romagnoli A, Giunta L, Di Bartolomeo S, Nardacci R, Corazzari M, Fuoco C, Ucar A, Schwartz P, et al. Ambra1 regulates autophagy and development of the nervous system. Nature 2007; 447:1121-5; PMID:17589504 (Pubitemid 47014434)
34. Cecconi F, Levine B. The role of autophagy in mammalian development: cell makeover rather than cell death. Dev Cell 2008; 15:344-57; PMID:18804433; http://dx.doi.org/10.1016/j. devcel.2008.08.012
35. Ku B, Woo JS, Liang C, Lee KH, Jung JU, Oh BH. An insight into the mechanistic role of Beclin 1 and its inhibition by prosurvival Bcl-2 family proteins. Autophagy 2008; 4:519-20; PMID:18334862 (Pubitemid 351705151)
36. Cao Y, Klionsky DJ. Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Res 2007; 17:839-49; PMID:17893711; http://dx.doi.org/10.1038/cr.2007.78 (Pubitemid 47585112)
37. Furuya N, Yu J, Byfield M, Pattingre S, Levine B. The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function. Autophagy 2005; 1:46-52; PMID:16874027; http://dx.doi.org/10.4161/auto.1.1.1542
38. Luo RZ, Fang X, Marquez R, Liu SY, Mills GB, Liao WS, Yu Y, Bast RC. ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers. Oncogene 2003; 22:2897-909; PMID:12771940; http://dx.doi.org/10.1038/sj.onc.1206380 (Pubitemid 36648916)
39. Luo RZ, Peng H, Xu F, Bao J, Pang Y, Pershad R, Issa JP, Liao WS, Bast RC Jr., Yu Y. Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARHI. Biochim Biophys Acta 2001; 1519:216-22; PMID:11418188; http://dx.doi.org/10.1016/S0167-4781(01)00226-3 (Pubitemid 32545431)
40. Itakura E, Mizushima N. Atg14 and UVRAG: mutually exclusive subunits of mammalian Beclin 1-PI3K complexes. Autophagy 2009; 5:534-6; PMID:19223761; http://dx.doi.org/10.4161/auto.5.4.8062
41. Vergne I, Roberts E, Elmaoued RA, Tosch V, Delgado MA, Proikas-Cezanne T, Laporte J, Deretic V. Control of autophagy initiation by phosphoinositide 3-phosphatase Jumpy. EMBO J 2009; 28:2244-58; PMID:19590496; http://dx.doi.org/10.1038/emboj.2009.159
42. Zeng X, Overmeyer JH, Maltese WA. Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking. J Cell Sci 2006; 119:259-70; PMID:16390869; http://dx.doi.org/10.1242/jcs.02735 (Pubitemid 43210695)
43. Matsunaga K, Noda T, Yoshimori T. Binding Rubicon to cross the Rubicon. Autophagy 2009; 5:876-7; PMID:19550146
44. Matsunaga K, Saitoh T, Tabata K, Omori H, Satoh T, Kurotori N, Maejima I, Shirahama-Noda K, Ichimura T, Isobe T, et al. Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nat Cell Biol 2009; 11:385-96; PMID:19270696; http://dx.doi.org/10.1038/ncb1846
45. Wei Y, Sinha S, Levine B. Dual role of JNK1-mediated phosphorylation of Bcl-2 in autophagy and apoptosis regulation. Autophagy 2008; 4:949-51; PMID:18769111
46. Maiuri MC, Criollo A, Tasdemir E, Vicencio JM, Tajeddine N, Hickman JA, Geneste O, Kroemer G. BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy 2007; 3:374-6; PMID:17438366 (Pubitemid 46986348)
47. Vicencio JM, Ortiz C, Criollo A, Jones AW, Kepp O, Galluzzi L, Joza N, Vitale I, Morselli E, Tailler M, et al. The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1. Cell Death Differ 2009; 16:1006-17; PMID:19325567; http://dx.doi.org/10.1038/cdd.2009.34
48. Shi CS, Kehrl JH. MyD88 and Trif target Beclin 1 to trigger autophagy in macrophages. J Biol Chem 2008; 283:33175-82; PMID:18772134; http://dx.doi.org/ 10.1074/jbc.M804478200
49. Noble CG, Dong JM, Manser E, Song H. Bcl-xL and UVRAG cause a monomer-dimer switch in Beclin1. J Biol Chem 2008; 283:26274-82; PMID:18641390; http://dx.doi.org/10.1074/jbc.M804723200
50. Li X, He L, Che KH, Funderburk SF, Pan L, Pan N, Zhang M, Yue Z, Zhao Y. Imperfect interface of Beclin1 coiled-coil domain regulates homodimer and heterodimer formation with Atg14L and UVRAG. Nat Commun 2012; 3:662; PMID:22314358; http://dx.doi.org/10.1038/ncomms1648
51. Kroep JR, Nortier JW. The role of bevacizumab in advanced epithelial ovarian cancer. Curr Pharm Des 2012; 18:3775-83; PMID:22591420; http://dx.doi.org/10.2174/138161212802002689
52. Aggarwal C, Somaiah N, Simon G. Antiangiogenic agents in the management of non-small cell lung cancer: where do we stand now and where are we headed? Cancer Biol Ther 2012; 13:247-63; PMID:22481432; http://dx.doi.org/10.4161/cbt. 19594
53. Sato S, Itamochi H. Bevacizumab and ovarian cancer. Curr Opin Obstet Gynecol 2012; 24:8-13; PMID:22123222; http://dx.doi.org/10.1097/GCO. 0b013e32834daeed
54. Tol J, Punt CJ. Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review. Clin Ther 2010; 32:437-53; PMID:20399983; http://dx.doi.org/10.1016/j.clinthera.2010.03.012
55. Badgwell DB, Lu Z, Le K, Gao F, Yang M, Suh GK, Bao JJ, Das P, Andreeff M, Chen W, et al. The tumorsuppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways. Oncogene 2012; 31:68-79; PMID:21643014; http://dx.doi.org/10.1038/onc. 2011.213
56. Klockenbusch C, Kast J. Optimization of formaldehyde cross-linking for protein interaction analysis of non-tagged integrin beta1. J Biomed Biotechnol 2010; 2010:927585; PMID:20634879; http://dx.doi.org/10.1155/2010/927585